Form 4: LeonaBio Director Peter Silverman Receives Stock Options
Director Equity Grant
Director Peter B. Silverman was granted 56,000 stock options in LeonaBio, Inc. as part of the company's 2026 Equity Incentive Plan.
Summary
- Director Peter B. Silverman received a grant of 56,000 stock options on May 5, 2026.
- The options have an exercise price of $9.63 per share.
- The options are scheduled to vest monthly over a 36-month period.
- The expiration date for these options is May 4, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
- Standard vesting schedule encourages long-term retention of board leadership.
Negatives
- Granting of stock options results in potential future dilution for existing shareholders.
Risks
- Future dilution of equity if options are exercised.
- Dependence on the director remaining a Service Provider to fulfill vesting requirements.
Future Outlook
The options vest monthly over 36 months, contingent upon the director's continued service to the company.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard practice in the biotechnology sector to incentivize board members and align their interests with long-term corporate performance.
Comparison to Industry Standards
- The 36-month vesting schedule is consistent with standard corporate governance practices for equity incentive plans in the biotech industry.
- The use of stock options as a component of director compensation is common among small-to-mid-cap life sciences companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan | Grant issued under the Issuer's 2026 Equity Incentive Plan. | 05/05/2026 | Formalizes the mechanism for director and employee equity compensation. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of these options.
Next Steps
- Vesting of options on a monthly basis over the next 36 months.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Date of the stock option grant transaction. |
| 05/07/2026 | Date the Form 4 was filed with the SEC. |
| 05/04/2036 | Expiration date of the granted stock options. |
Keywords
LeonaBio, LONA, Form 4, Insider Trading, Stock Options, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.